Mandate

Axel Johnson AB become new principal owner of Mekonomen AB (publ)

October 02, 2006

Axel Johnson is becoming the new principal owner in Mekonomen by acquiring shares corresponding to 29 percent of the capital and votes from the Fraim and Möller families, after restamping all A-shares to B-shares. In connection with the acquisition of the shares, Axel Johnson AB has also agreed to an option that gives Axel Johnson AB the right to further acquire up to 9.9 percent of the total number of shares.

Vinge acted as advisor to the sellers Fraim and Möller. Representatives from Vinge included Carl Gustaf De Geer, Malin Ohlin Åkermark and Daniel Rosvall.

Related

Vinge advises Trianon in connection with directed share issue and tender offer for subordinated sustainable capital securities

Vinge advises Fastighets Aktiebolaget Trianon (publ) in connection with a directed share issue of SEK 184 million and a tender offer for outstanding subordinated perpetual floating rate callable sustainable capital securities.
April 19, 2024

Vinge advises Blackstone in connection with its investment in Winthrop Technologies

Vinge, as local Swedish counsel, advised Blackstone Tactical Opportunities and affiliated funds (“Blackstone”) in connection with a strategic partnership with Winthrop Technologies Limited (“Winthrop Technologies”).
April 17, 2024

Vinge has advised Hansa Biopharma in connection with a directed share issue of SEK 372 million

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of SEK 372 million before transaction costs. Hansa Biopharma is a commercial-stage biopharmaceutical company pioneering the development and commercialization of innovative, lifesaving and life altering treatments for patients with rare immunological conditions. Hansa Biopharma’s ordinary share is listed on Nasdaq Stockholm.
April 16, 2024